ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,425Medicare Part D Prescriptions Filled, Including Refills

Rank: 482 out of 5176

$1.25M Total Retail Price of All Prescriptions

Rank: 159 out of 5176

407 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 10,361 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

52% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$109 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 502 419 1 1
ATORVASTATIN CALCIUM 412 393 2 9
METFORMIN HCL ER 357 318 3 57
AMLODIPINE BESYLATE 352 324 4 2
ALENDRONATE SODIUM 340 326 5 18
MICARDIS 340 339 10 5 154
METFORMIN HCL 338 307 7 7
LOSARTAN POTASSIUM 296 251 8 14
LISINOPRIL 268 237 9 5
CRESTOR 242 226 10 15
LOVAZA 231 220 11 43
DIOVAN 220 169 12 19
ALLOPURINOL 205 173 13 41
LIDODERM 188 176 14 59
EVISTA 185 173 15 65
LEVOTHYROXINE SODIUM 185 159 15 4
ACTOS 185 175 15 85
MICARDIS HCT 181 172 18 180
ADVAIR DISKUS 157 149 19 32
OMEPRAZOLE 152 127 20 3
PRAVASTATIN SODIUM 147 131 21 23
BENICAR 136 131 22 100
PLAVIX 130 130 23 29
CIPROFLOXACIN HCL 126 113 24 84
FLUTICASONE PROPIONATE 121 105 25 38
JANUVIA 119 105 26 25
VOLTAREN 118 110 27 97
TAMSULOSIN HCL 111 102 28 20
NEXIUM 109 95 29 16
TRIAMCINOLONE ACETONIDE 108 82 30 125
AZITHROMYCIN 104 96 31 42
CLOPIDOGREL 101 101 32 26
SPIRIVA 99 99 33 54
CALCITRIOL 95 95 34 261
GLIPIZIDE XL 90 76 35 83
ATENOLOL 88 84 36 12
AMMONIUM LACTATE 85 83 37 91
LIPITOR 83 80 38 51
AVODART 83 77 38 107
ACTONEL 80 78 40 134
GLIMEPIRIDE 79 74 41 37
DIOVAN HCT 78 72 42 39
ONGLYZA 77 77 43 153
PIOGLITAZONE HCL 76 60 R 44 237
PATANOL 76 62 44 158
ZEMPLAR 73 73 46 435
PROAIR HFA 71 65 47 60
INDAPAMIDE 69 65 48 257
SINGULAIR 66 61 49 62
CARVEDILOL 66 56 49 24
PRADAXA 66 66 49 192
FINASTERIDE 63 59 52 69
NASONEX 60 51 53 178
TRICOR 59 45 54 148
BYSTOLIC 58 58 55 96
CICLOPIROX 57 49 56 279
CELEBREX 55 53 57 80
SINGLE USE SWAB 54 51 58 108
BETAMETHASONE DIPROPIONATE 54 49 58 260
ZOLPIDEM TARTRATE 52 45 60 17
PROCRIT 52 52 60 367
ULORIC 51 48 62 280
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.